Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer

Alexander Haug, Thomas Helbich, Wolfgang Wadsak, Sarah Pfaff, Martin Susani, Shahrokh Shariat, Marcus Hacker, Sabrina Hartenbach, Jan-Marc Lieskovsky and Markus Hartenbach
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1436;
Alexander Haug
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Helbich
2Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Wadsak
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Pfaff
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Susani
3Institute of Pathology, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahrokh Shariat
4Department of Urology, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Hartenbach
5Pathology, Federal Armed Forces, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Marc Lieskovsky
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Hartenbach
1Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1436

Objectives We aimed to analyse the dynamic uptake of [68Ga]PSMAHBED-CC of primary prostate cancer (PC) and to identify Gleason score specific patterns.

Methods 14 patients with biopsy proven PC were examined prior to prostatectomy. After injection of 2 MBq/kg [68Ga]PSMAHBED-CC list mode scanning for 45 minutes with a Siemens mMR was started. Simultaneously T2w, DWI, DCE and 3D SPACE sequences using an endorectal coil were acquired. The PC was identified using all MRI sequences and focal [68Ga]PSMAHBED-CC uptake and validated on histological whole mount sections including Gleason grading and score (GS). VOI time-activity-curves (TAC) were generated with 2 minute frames.

Results Two patients had GS 6, 7 GS 3+4, 3 GS 4+3, and 2 GS 8. All PC were diagnosed on [68Ga]PSMAHBED-CC PET. All PC with GS 6 and 6 of 7 GS 3+4 showed an initial steep increase of [68Ga]PSMA with a peak within 5 minutes followed by a successive decline until minute 45 p.i.. One PC with GS 3+4 showed an increasing TAC until minute 6 and then reaching a plateau. All PC with GS 4+3 as well as GS 8 had an increasing TAC over time.

Conclusions We identified two different TAC: an early peak followed from a decreasing uptake in low GS, and an increasing TAC in higher GS. This is very preliminary but promising data and is verified in a larger patient population at the moment.

Research Support None.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer
Alexander Haug, Thomas Helbich, Wolfgang Wadsak, Sarah Pfaff, Martin Susani, Shahrokh Shariat, Marcus Hacker, Sabrina Hartenbach, Jan-Marc Lieskovsky, Markus Hartenbach
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1436;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer
Alexander Haug, Thomas Helbich, Wolfgang Wadsak, Sarah Pfaff, Martin Susani, Shahrokh Shariat, Marcus Hacker, Sabrina Hartenbach, Jan-Marc Lieskovsky, Markus Hartenbach
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1436;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Time of Flight compared to standard iterative acquisition and reconstruction for assessment of pulmonary nodules.
  • Is childhood obesity linked to lymphoma?
Show more Oncology: Clinical Diagnosis

MTA I: Prostate/GU Posters

  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • Comparative assessment of skeletal uptake on Ga-68 PSMA PET/CT versus F-18 Fluoride PET/CT in metastatic prostate cancer
  • 18F-FDG PET/CT in the follow-up of asymptomatic RCC patients after surgery : Can substitute conventional imaging?
Show more MTA I: Prostate/GU Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire